Toronto Dominion Bank’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Toronto Dominion Bank’s Portfolio CPHR Stock Details CPHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-40	Closed	–	–	1377
2016 Q3	$0	Sell	40 -25	-38%	-$114	﹤0.01%	1309
2016 Q2	$0	Buy	65 +51	+364%	+$291	﹤0.01%	1354
2016 Q1	$0	Sell	14 -30	-68%	-$132	﹤0.01%	1345
2015 Q4	$0	Buy	+44	New	+$190	﹤0.01%	1152
2015 Q3	–	Sell	-76	Closed	-$1K	–	1164
2015 Q2	$1K	Buy	76 +5	+7%	+$50	﹤0.01%	1081
2015 Q1	$1K	Buy	+71	New	+$892	﹤0.01%	1060

Other funds holding CPHR

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

NEI

Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Toronto Dominion Bank's CPHR Position: Q4 2016 in Review

Toronto Dominion Bank sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q4 2016, closing a stake of 40 shares.

Toronto Dominion Bank first reported a position in CPHR in Q1 2015 and held it in 6 quarters. The position peaked at $1K in Q2 2015. 3 funds tracked by Wall St. Rank hold CPHR as of Q4 2016.

Toronto Dominion Bank reported no remaining Cipher Pharmaceuticals Inc. position as of Q4 2016 after selling out during the quarter.
Toronto Dominion Bank sold 40 Cipher Pharmaceuticals Inc. shares in Q4 2016.
Toronto Dominion Bank first reported a position in Cipher Pharmaceuticals Inc. in Q1 2015 and held it in 6 quarters.
Toronto Dominion Bank's Cipher Pharmaceuticals Inc. position peaked at $1K in Q2 2015.
3 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q4 2016.

Based on Toronto Dominion Bank's 13F filing for Q4 2016, filed 6 Feb 2017.